http://www.mypharma-editions.com L'Info Industrie & Politique de Santé Wed, 15 Feb 2012 14:04:44 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 http://www.mypharma-editions.com/maladies-metaboliques-kinemed-annonce-sa-collaboration-avec-pfizer http://www.mypharma-editions.com/maladies-metaboliques-kinemed-annonce-sa-collaboration-avec-pfizer#comments Wed, 01 Feb 2012 08:56:03 +0000 morgdave http://www.mypharma-editions.com/?p=23288 http://www.mypharma-editions.com/maladies-metaboliques-kinemed-annonce-sa-collaboration-avec-pfizer/feed 0 http://www.mypharma-editions.com/diabete-de-type-2-la-regulation-de-lhorloge-biologique-en-cause http://www.mypharma-editions.com/diabete-de-type-2-la-regulation-de-lhorloge-biologique-en-cause#comments Mon, 30 Jan 2012 15:21:25 +0000 morgdave http://www.mypharma-editions.com/?p=23254 http://www.mypharma-editions.com/diabete-de-type-2-la-regulation-de-lhorloge-biologique-en-cause/feed 0 http://www.mypharma-editions.com/diabete-de-type-2-roche-et-lihu-ican-partenaires-pour-identifier-des-voies-de-signalisation-et-des-cibles-moleculaires http://www.mypharma-editions.com/diabete-de-type-2-roche-et-lihu-ican-partenaires-pour-identifier-des-voies-de-signalisation-et-des-cibles-moleculaires#comments Wed, 25 Jan 2012 08:43:54 +0000 morgdave http://www.mypharma-editions.com/?p=23183 http://www.mypharma-editions.com/diabete-de-type-2-roche-et-lihu-ican-partenaires-pour-identifier-des-voies-de-signalisation-et-des-cibles-moleculaires/feed 0 http://www.mypharma-editions.com/arret-de-letude-clinique-altitude-avec-rasilez http://www.mypharma-editions.com/arret-de-letude-clinique-altitude-avec-rasilez#comments Thu, 22 Dec 2011 16:09:05 +0000 morgdave http://www.mypharma-editions.com/?p=22892 http://www.mypharma-editions.com/arret-de-letude-clinique-altitude-avec-rasilez/feed 0 http://www.mypharma-editions.com/diabete-et-risque-de-cancer-une-meta-analyse-confirme-la-securite-de-lantus%c2%ae-de-sanofi http://www.mypharma-editions.com/diabete-et-risque-de-cancer-une-meta-analyse-confirme-la-securite-de-lantus%c2%ae-de-sanofi#comments Thu, 08 Dec 2011 07:40:15 +0000 morgdave http://www.mypharma-editions.com/?p=22623 http://www.mypharma-editions.com/diabete-et-risque-de-cancer-une-meta-analyse-confirme-la-securite-de-lantus%c2%ae-de-sanofi/feed 0 http://www.mypharma-editions.com/diabete-resultats-positifs-pour-lyxumia%c2%ae-de-sanofi http://www.mypharma-editions.com/diabete-resultats-positifs-pour-lyxumia%c2%ae-de-sanofi#comments Tue, 06 Dec 2011 08:59:53 +0000 morgdave http://www.mypharma-editions.com/?p=22587 http://www.mypharma-editions.com/diabete-resultats-positifs-pour-lyxumia%c2%ae-de-sanofi/feed 0 http://www.mypharma-editions.com/une-nouvelle-approche-pour-le-traitement-des-maladies-auto-immunes http://www.mypharma-editions.com/une-nouvelle-approche-pour-le-traitement-des-maladies-auto-immunes#comments Thu, 01 Dec 2011 13:39:05 +0000 morgdave http://www.mypharma-editions.com/?p=22542 http://www.mypharma-editions.com/une-nouvelle-approche-pour-le-traitement-des-maladies-auto-immunes/feed 0 http://www.mypharma-editions.com/diabete-feu-vert-europeen-pour-onglyza%c2%ae-de-bristol-myers-squibb-et-astrazeneca http://www.mypharma-editions.com/diabete-feu-vert-europeen-pour-onglyza%c2%ae-de-bristol-myers-squibb-et-astrazeneca#comments Mon, 28 Nov 2011 13:31:46 +0000 morgdave http://www.mypharma-editions.com/?p=22494 http://www.mypharma-editions.com/diabete-feu-vert-europeen-pour-onglyza%c2%ae-de-bristol-myers-squibb-et-astrazeneca/feed 0 http://www.mypharma-editions.com/genfit-nouvelles-donnees-precliniques-positives-pour-le-gft505 http://www.mypharma-editions.com/genfit-nouvelles-donnees-precliniques-positives-pour-le-gft505#comments Sat, 26 Nov 2011 08:59:59 +0000 morgdave http://www.mypharma-editions.com/?p=22480 http://www.mypharma-editions.com/genfit-nouvelles-donnees-precliniques-positives-pour-le-gft505/feed 0 http://www.mypharma-editions.com/diabete-lonu-appelle-a-faciliter-lacces-aux-traitements http://www.mypharma-editions.com/diabete-lonu-appelle-a-faciliter-lacces-aux-traitements#comments Tue, 15 Nov 2011 10:11:29 +0000 morgdave http://www.mypharma-editions.com/?p=22285 http://www.mypharma-editions.com/diabete-lonu-appelle-a-faciliter-lacces-aux-traitements/feed 0 http://www.mypharma-editions.com/journee-mondiale-du-diabete-356-millions-de-diabetiques-dans-le-monde http://www.mypharma-editions.com/journee-mondiale-du-diabete-356-millions-de-diabetiques-dans-le-monde#comments Mon, 14 Nov 2011 14:20:40 +0000 morgdave http://www.mypharma-editions.com/?p=22266 http://www.mypharma-editions.com/journee-mondiale-du-diabete-356-millions-de-diabetiques-dans-le-monde/feed 1 http://www.mypharma-editions.com/diabete-cellectis-prend-une-longueur-d%e2%80%99avance-dans-la-recherche-de-futurs-traitements http://www.mypharma-editions.com/diabete-cellectis-prend-une-longueur-d%e2%80%99avance-dans-la-recherche-de-futurs-traitements#comments Thu, 10 Nov 2011 15:05:07 +0000 morgdave http://www.mypharma-editions.com/?p=22208 http://www.mypharma-editions.com/diabete-cellectis-prend-une-longueur-d%e2%80%99avance-dans-la-recherche-de-futurs-traitements/feed 0 http://www.mypharma-editions.com/diabete-1ere-experimentation-dun-pancreas-artificiel http://www.mypharma-editions.com/diabete-1ere-experimentation-dun-pancreas-artificiel#comments Wed, 02 Nov 2011 12:43:09 +0000 morgdave http://www.mypharma-editions.com/?p=22023 http://www.mypharma-editions.com/diabete-1ere-experimentation-dun-pancreas-artificiel/feed 0 http://www.mypharma-editions.com/genfit-une-etude-en-milieu-hospitalier-demontre-laction-de-gft505-sur-le-foie http://www.mypharma-editions.com/genfit-une-etude-en-milieu-hospitalier-demontre-laction-de-gft505-sur-le-foie#comments Thu, 20 Oct 2011 17:03:06 +0000 morgdave http://www.mypharma-editions.com/?p=21821 http://www.mypharma-editions.com/genfit-une-etude-en-milieu-hospitalier-demontre-laction-de-gft505-sur-le-foie/feed 0 http://www.mypharma-editions.com/diabete-roche-recoit-le-feu-vert-de-la-fda-pour-son-systeme-de-test-accu-chek-aviva-plus http://www.mypharma-editions.com/diabete-roche-recoit-le-feu-vert-de-la-fda-pour-son-systeme-de-test-accu-chek-aviva-plus#comments Thu, 29 Sep 2011 07:41:37 +0000 morgdave http://www.mypharma-editions.com/?p=21340 http://www.mypharma-editions.com/diabete-roche-recoit-le-feu-vert-de-la-fda-pour-son-systeme-de-test-accu-chek-aviva-plus/feed 1 http://www.mypharma-editions.com/diabete-1ere-lignee-de-cellules-pancreatiques-humaines-productrices-et-secretrices-dinsuline http://www.mypharma-editions.com/diabete-1ere-lignee-de-cellules-pancreatiques-humaines-productrices-et-secretrices-dinsuline#comments Mon, 26 Sep 2011 12:36:23 +0000 morgdave http://www.mypharma-editions.com/?p=21243 http://www.mypharma-editions.com/diabete-1ere-lignee-de-cellules-pancreatiques-humaines-productrices-et-secretrices-dinsuline/feed 0 http://www.mypharma-editions.com/diabete-resultats-positifs-pour-onglyza%e2%84%a2-d%e2%80%99astrazeneca-et-bms http://www.mypharma-editions.com/diabete-resultats-positifs-pour-onglyza%e2%84%a2-d%e2%80%99astrazeneca-et-bms#comments Sat, 17 Sep 2011 12:46:42 +0000 morgdave http://www.mypharma-editions.com/?p=21035 http://www.mypharma-editions.com/diabete-resultats-positifs-pour-onglyza%e2%84%a2-d%e2%80%99astrazeneca-et-bms/feed 0 http://www.mypharma-editions.com/diabete-sanofi-signe-un-accord-pour-le-developpement-de-diabeo-une-solution-de-telemedecine http://www.mypharma-editions.com/diabete-sanofi-signe-un-accord-pour-le-developpement-de-diabeo-une-solution-de-telemedecine#comments Tue, 13 Sep 2011 09:20:55 +0000 morgdave http://www.mypharma-editions.com/?p=20920 http://www.mypharma-editions.com/diabete-sanofi-signe-un-accord-pour-le-developpement-de-diabeo-une-solution-de-telemedecine/feed 0 http://www.mypharma-editions.com/diabete-de-type-2-nouvelles-donnees-positives-pour-lyxumia%c2%ae-et-lantus%c2%ae-de-sanofi http://www.mypharma-editions.com/diabete-de-type-2-nouvelles-donnees-positives-pour-lyxumia%c2%ae-et-lantus%c2%ae-de-sanofi#comments Mon, 12 Sep 2011 13:13:07 +0000 morgdave http://www.mypharma-editions.com/?p=20895 http://www.mypharma-editions.com/diabete-de-type-2-nouvelles-donnees-positives-pour-lyxumia%c2%ae-et-lantus%c2%ae-de-sanofi/feed 1 http://www.mypharma-editions.com/diabete-de-type-2-accord-mondial-entre-servier-et-lamericain-intercept http://www.mypharma-editions.com/diabete-de-type-2-accord-mondial-entre-servier-et-lamericain-intercept#comments Wed, 10 Aug 2011 08:15:08 +0000 morgdave http://www.mypharma-editions.com/?p=20547 http://www.mypharma-editions.com/diabete-de-type-2-accord-mondial-entre-servier-et-lamericain-intercept/feed 0 http://www.mypharma-editions.com/genfit-renforce-sa-tresorerie-de-7-5-m-e-pour-poursuivre-ses-developpements http://www.mypharma-editions.com/genfit-renforce-sa-tresorerie-de-7-5-m-e-pour-poursuivre-ses-developpements#comments Wed, 20 Jul 2011 12:28:56 +0000 morgdave http://www.mypharma-editions.com/?p=20370 http://www.mypharma-editions.com/genfit-renforce-sa-tresorerie-de-7-5-m-e-pour-poursuivre-ses-developpements/feed 0 http://www.mypharma-editions.com/genfit-letude-gft505-210-5-confirme-le-large-spectre-daction-de-gft505-chez-le-patient-diabetique http://www.mypharma-editions.com/genfit-letude-gft505-210-5-confirme-le-large-spectre-daction-de-gft505-chez-le-patient-diabetique#comments Wed, 13 Jul 2011 09:41:52 +0000 morgdave http://www.mypharma-editions.com/?p=20277 http://www.mypharma-editions.com/genfit-letude-gft505-210-5-confirme-le-large-spectre-daction-de-gft505-chez-le-patient-diabetique/feed 0 http://www.mypharma-editions.com/diabete-de-type-1-adocia-demarre-une-etude-clinique-de-phase-iia-avec-son-insuline-humaine-a-action-rapide-hinsbet-%c2%ae http://www.mypharma-editions.com/diabete-de-type-1-adocia-demarre-une-etude-clinique-de-phase-iia-avec-son-insuline-humaine-a-action-rapide-hinsbet-%c2%ae#comments Mon, 27 Jun 2011 12:05:41 +0000 morgdave http://www.mypharma-editions.com/?p=20003 http://www.mypharma-editions.com/diabete-de-type-1-adocia-demarre-une-etude-clinique-de-phase-iia-avec-son-insuline-humaine-a-action-rapide-hinsbet-%c2%ae/feed 0 http://www.mypharma-editions.com/sanofi-resultats-positifs-pour-lantus%c2%ae-et-apidra%c2%ae-dans-le-diabete-de-type-2 http://www.mypharma-editions.com/sanofi-resultats-positifs-pour-lantus%c2%ae-et-apidra%c2%ae-dans-le-diabete-de-type-2#comments Mon, 27 Jun 2011 07:32:58 +0000 morgdave http://www.mypharma-editions.com/?p=19985 http://www.mypharma-editions.com/sanofi-resultats-positifs-pour-lantus%c2%ae-et-apidra%c2%ae-dans-le-diabete-de-type-2/feed 0 http://www.mypharma-editions.com/le-nombre-de-diabetiques-aurait-plus-que-double-en-30-ans http://www.mypharma-editions.com/le-nombre-de-diabetiques-aurait-plus-que-double-en-30-ans#comments Mon, 27 Jun 2011 07:03:26 +0000 morgdave http://www.mypharma-editions.com/?p=19983 http://www.mypharma-editions.com/le-nombre-de-diabetiques-aurait-plus-que-double-en-30-ans/feed 0 http://www.mypharma-editions.com/diabete-genfit-presentera-les-donnees-cliniques-de-l%e2%80%99etude-gft505-210-5-le-13-juillet-prochain http://www.mypharma-editions.com/diabete-genfit-presentera-les-donnees-cliniques-de-l%e2%80%99etude-gft505-210-5-le-13-juillet-prochain#comments Sat, 18 Jun 2011 08:02:08 +0000 morgdave http://www.mypharma-editions.com/?p=19820 http://www.mypharma-editions.com/diabete-genfit-presentera-les-donnees-cliniques-de-l%e2%80%99etude-gft505-210-5-le-13-juillet-prochain/feed 0 http://www.mypharma-editions.com/investissements-davenir-l%e2%80%99effort-de-recherche-sur-lobesite-multiplie-par-six http://www.mypharma-editions.com/investissements-davenir-l%e2%80%99effort-de-recherche-sur-lobesite-multiplie-par-six#comments Wed, 01 Jun 2011 08:12:45 +0000 morgdave http://www.mypharma-editions.com/?p=19523 http://www.mypharma-editions.com/investissements-davenir-l%e2%80%99effort-de-recherche-sur-lobesite-multiplie-par-six/feed 0 http://www.mypharma-editions.com/sanofi-resultats-positifs-en-phase-iii-pour-lyxumia%c2%ae-dans-le-diabete http://www.mypharma-editions.com/sanofi-resultats-positifs-en-phase-iii-pour-lyxumia%c2%ae-dans-le-diabete#comments Tue, 31 May 2011 06:53:21 +0000 morgdave http://www.mypharma-editions.com/?p=19498 http://www.mypharma-editions.com/sanofi-resultats-positifs-en-phase-iii-pour-lyxumia%c2%ae-dans-le-diabete/feed 0 http://www.mypharma-editions.com/diabete-sanofi-partenaire-d%e2%80%99un-programme-de-prise-en-charge-en-chine http://www.mypharma-editions.com/diabete-sanofi-partenaire-d%e2%80%99un-programme-de-prise-en-charge-en-chine#comments Wed, 11 May 2011 07:24:33 +0000 morgdave http://www.mypharma-editions.com/?p=19130 http://www.mypharma-editions.com/diabete-sanofi-partenaire-d%e2%80%99un-programme-de-prise-en-charge-en-chine/feed 0 http://www.mypharma-editions.com/has-de-nouvelles-recommandations-sur-le-diabete-de-type-2-pour-debut-2012 http://www.mypharma-editions.com/has-de-nouvelles-recommandations-sur-le-diabete-de-type-2-pour-debut-2012#comments Wed, 04 May 2011 07:58:47 +0000 morgdave http://www.mypharma-editions.com/?p=19028 http://www.mypharma-editions.com/has-de-nouvelles-recommandations-sur-le-diabete-de-type-2-pour-debut-2012/feed 3 http://www.mypharma-editions.com/lafssaps-met-en-garde-diabete-risque-accru-de-cancer-de-la-vessie-chez-les-patients-traites-par-pioglitazone-actos%c2%ae-competact%c2%ae http://www.mypharma-editions.com/lafssaps-met-en-garde-diabete-risque-accru-de-cancer-de-la-vessie-chez-les-patients-traites-par-pioglitazone-actos%c2%ae-competact%c2%ae#comments Wed, 20 Apr 2011 07:55:48 +0000 morgdave http://www.mypharma-editions.com/?p=18834 http://www.mypharma-editions.com/lafssaps-met-en-garde-diabete-risque-accru-de-cancer-de-la-vessie-chez-les-patients-traites-par-pioglitazone-actos%c2%ae-competact%c2%ae/feed 0 http://www.mypharma-editions.com/une-nouvelle-biotherapie-contre-le-cancer-et-la-perte-de-vision http://www.mypharma-editions.com/une-nouvelle-biotherapie-contre-le-cancer-et-la-perte-de-vision#comments Tue, 12 Apr 2011 11:39:45 +0000 morgdave http://www.mypharma-editions.com/?p=18697 http://www.mypharma-editions.com/une-nouvelle-biotherapie-contre-le-cancer-et-la-perte-de-vision/feed 1 http://www.mypharma-editions.com/bayer-et-regeneron-etude-clinique-de-phase-iii-sur-vegf-trap-eye-dans-loedeme-maculaire-diabetique http://www.mypharma-editions.com/bayer-et-regeneron-etude-clinique-de-phase-iii-sur-vegf-trap-eye-dans-loedeme-maculaire-diabetique#comments Tue, 12 Apr 2011 08:05:35 +0000 morgdave http://www.mypharma-editions.com/?p=18689 http://www.mypharma-editions.com/bayer-et-regeneron-etude-clinique-de-phase-iii-sur-vegf-trap-eye-dans-loedeme-maculaire-diabetique/feed 0 http://www.mypharma-editions.com/diabete-de-type-2-resultats-positifs-pour-lixisenatide-de-sanofi-aventis http://www.mypharma-editions.com/diabete-de-type-2-resultats-positifs-pour-lixisenatide-de-sanofi-aventis#comments Tue, 12 Apr 2011 06:43:05 +0000 morgdave http://www.mypharma-editions.com/?p=18677 http://www.mypharma-editions.com/diabete-de-type-2-resultats-positifs-pour-lixisenatide-de-sanofi-aventis/feed 0 http://www.mypharma-editions.com/diabete-resultats-cliniques-positifs-de-phase-i-pour-hinsbet%c2%ae-une-insuline-humaine-d%e2%80%99action-rapide http://www.mypharma-editions.com/diabete-resultats-cliniques-positifs-de-phase-i-pour-hinsbet%c2%ae-une-insuline-humaine-d%e2%80%99action-rapide#comments Wed, 16 Mar 2011 14:37:09 +0000 morgdave http://www.mypharma-editions.com/?p=18132 http://www.mypharma-editions.com/diabete-resultats-cliniques-positifs-de-phase-i-pour-hinsbet%c2%ae-une-insuline-humaine-d%e2%80%99action-rapide/feed 0 http://www.mypharma-editions.com/diabete-sanofi-aventis-annonce-des-resultats-positifs-de-phase-iii-pour-lixisenatide http://www.mypharma-editions.com/diabete-sanofi-aventis-annonce-des-resultats-positifs-de-phase-iii-pour-lixisenatide#comments Wed, 02 Feb 2011 08:39:00 +0000 morgdave http://www.mypharma-editions.com/?p=17409 http://www.mypharma-editions.com/diabete-sanofi-aventis-annonce-des-resultats-positifs-de-phase-iii-pour-lixisenatide/feed 0 http://www.mypharma-editions.com/le-tissu-adipeux-produit-des-cellules-impliquees-dans-la-reponse-immunitaire http://www.mypharma-editions.com/le-tissu-adipeux-produit-des-cellules-impliquees-dans-la-reponse-immunitaire#comments Thu, 25 Nov 2010 13:15:19 +0000 morgdave http://www.mypharma-editions.com/?p=15909 http://www.mypharma-editions.com/le-tissu-adipeux-produit-des-cellules-impliquees-dans-la-reponse-immunitaire/feed 0 http://www.mypharma-editions.com/journee-mondiale-du-diabete-le-14-novembre-2010 http://www.mypharma-editions.com/journee-mondiale-du-diabete-le-14-novembre-2010#comments Thu, 11 Nov 2010 14:27:04 +0000 morgdave http://www.mypharma-editions.com/?p=15405 http://www.mypharma-editions.com/journee-mondiale-du-diabete-le-14-novembre-2010/feed 1 http://www.mypharma-editions.com/3-millions-de-diabetiques-en-france-en-2009-selon-linvs http://www.mypharma-editions.com/3-millions-de-diabetiques-en-france-en-2009-selon-linvs#comments Tue, 09 Nov 2010 10:40:11 +0000 morgdave http://www.mypharma-editions.com/?p=15288 http://www.mypharma-editions.com/3-millions-de-diabetiques-en-france-en-2009-selon-linvs/feed 0 http://www.mypharma-editions.com/diabete-de-l%e2%80%99enfant-nouvelle-campagne-nationale-le-14-novembre-prochain http://www.mypharma-editions.com/diabete-de-l%e2%80%99enfant-nouvelle-campagne-nationale-le-14-novembre-prochain#comments Mon, 08 Nov 2010 13:42:07 +0000 morgdave http://www.mypharma-editions.com/?p=15248 http://www.mypharma-editions.com/diabete-de-l%e2%80%99enfant-nouvelle-campagne-nationale-le-14-novembre-prochain/feed 1 http://www.mypharma-editions.com/sanofi-aventis-resultats-d%e2%80%99une-etude-de-phase-iii-sur-lixisenatide-en-association-a-une-insuline-basale http://www.mypharma-editions.com/sanofi-aventis-resultats-d%e2%80%99une-etude-de-phase-iii-sur-lixisenatide-en-association-a-une-insuline-basale#comments Thu, 30 Sep 2010 08:22:45 +0000 morgdave http://www.mypharma-editions.com/?p=14022 http://www.mypharma-editions.com/sanofi-aventis-resultats-d%e2%80%99une-etude-de-phase-iii-sur-lixisenatide-en-association-a-une-insuline-basale/feed 0 http://www.mypharma-editions.com/janssen-et-la-fondation-europeenne-pour-letude-du-diabete-vont-cofinancer-un-programme-de-recherche http://www.mypharma-editions.com/janssen-et-la-fondation-europeenne-pour-letude-du-diabete-vont-cofinancer-un-programme-de-recherche#comments Mon, 27 Sep 2010 07:23:41 +0000 morgdave http://www.mypharma-editions.com/?p=13947 http://www.mypharma-editions.com/janssen-et-la-fondation-europeenne-pour-letude-du-diabete-vont-cofinancer-un-programme-de-recherche/feed 0 http://www.mypharma-editions.com/diabete-nouvelles-avancees-pour-la-therapie-cellulaire http://www.mypharma-editions.com/diabete-nouvelles-avancees-pour-la-therapie-cellulaire#comments Fri, 24 Sep 2010 11:41:36 +0000 morgdave http://www.mypharma-editions.com/?p=13929 http://www.mypharma-editions.com/diabete-nouvelles-avancees-pour-la-therapie-cellulaire/feed 0 http://www.mypharma-editions.com/diabete-sanofi-aventis-presente-ses-nouveaux-lecteurs-de-glycemie http://www.mypharma-editions.com/diabete-sanofi-aventis-presente-ses-nouveaux-lecteurs-de-glycemie#comments Tue, 21 Sep 2010 07:16:57 +0000 morgdave http://www.mypharma-editions.com/?p=13801 http://www.mypharma-editions.com/diabete-sanofi-aventis-presente-ses-nouveaux-lecteurs-de-glycemie/feed 0 http://www.mypharma-editions.com/diabete-lancement-du-projet-imidia-de-linnovative-medicines-initiative-imi http://www.mypharma-editions.com/diabete-lancement-du-projet-imidia-de-linnovative-medicines-initiative-imi#comments Mon, 14 Jun 2010 07:26:23 +0000 morgdave http://www.mypharma-editions.com/?p=12836 http://www.mypharma-editions.com/diabete-lancement-du-projet-imidia-de-linnovative-medicines-initiative-imi/feed 0 http://www.mypharma-editions.com/cancer-et-diabete-une-decouverte-deux-pistes-de-recherche http://www.mypharma-editions.com/cancer-et-diabete-une-decouverte-deux-pistes-de-recherche#comments Wed, 05 May 2010 07:30:39 +0000 morgdave http://www.mypharma-editions.com/?p=12494 http://www.mypharma-editions.com/cancer-et-diabete-une-decouverte-deux-pistes-de-recherche/feed 1 http://www.mypharma-editions.com/diabete-lafssaps-suspend-lamm-de-trois-medicaments-contenant-du-benfluorex http://www.mypharma-editions.com/diabete-lafssaps-suspend-lamm-de-trois-medicaments-contenant-du-benfluorex#comments Fri, 27 Nov 2009 09:16:46 +0000 morgdave http://www.mypharma-editions.com/?p=10537 http://www.mypharma-editions.com/diabete-lafssaps-suspend-lamm-de-trois-medicaments-contenant-du-benfluorex/feed 0 http://www.mypharma-editions.com/diabete-25-millions-de-personnes-atteintes-en-france http://www.mypharma-editions.com/diabete-25-millions-de-personnes-atteintes-en-france#comments Thu, 22 Oct 2009 14:25:03 +0000 morgdave http://www.mypharma-editions.com/?p=9851 http://www.mypharma-editions.com/diabete-25-millions-de-personnes-atteintes-en-france/feed 0 http://www.mypharma-editions.com/diabete-mise-a-jour-du-dossier-thematique-de-l%e2%80%99invs http://www.mypharma-editions.com/diabete-mise-a-jour-du-dossier-thematique-de-l%e2%80%99invs#comments Tue, 06 Oct 2009 10:49:26 +0000 morgdave http://www.mypharma-editions.com/?p=9004 http://www.mypharma-editions.com/diabete-mise-a-jour-du-dossier-thematique-de-l%e2%80%99invs/feed 0 http://www.mypharma-editions.com/diabete-eli-lilly-et-macrogenics-concluent-le-recrutement-cible-de-patients-de-l%e2%80%99essai-clinique-mondial-protege http://www.mypharma-editions.com/diabete-eli-lilly-et-macrogenics-concluent-le-recrutement-cible-de-patients-de-l%e2%80%99essai-clinique-mondial-protege#comments Wed, 17 Jun 2009 08:30:47 +0000 morgdave http://www.mypharma-editions.com/?p=6733 http://www.mypharma-editions.com/diabete-eli-lilly-et-macrogenics-concluent-le-recrutement-cible-de-patients-de-l%e2%80%99essai-clinique-mondial-protege/feed 0 http://www.mypharma-editions.com/lancement-de-l%e2%80%99institut-europeen-de-genomique-du-diabete-a-lille http://www.mypharma-editions.com/lancement-de-l%e2%80%99institut-europeen-de-genomique-du-diabete-a-lille#comments Tue, 26 May 2009 08:36:10 +0000 morgdave http://www.mypharma-editions.com/?p=6123 http://www.mypharma-editions.com/lancement-de-l%e2%80%99institut-europeen-de-genomique-du-diabete-a-lille/feed 0 http://www.mypharma-editions.com/etude-entred-la-prise-en-charge-du-diabete-de-type-2-s%e2%80%99ameliore-mais-des-progres-restent-a-faire http://www.mypharma-editions.com/etude-entred-la-prise-en-charge-du-diabete-de-type-2-s%e2%80%99ameliore-mais-des-progres-restent-a-faire#comments Tue, 17 Mar 2009 15:59:10 +0000 morgdave http://www.mypharma-editions.com/?p=4934 http://www.mypharma-editions.com/etude-entred-la-prise-en-charge-du-diabete-de-type-2-s%e2%80%99ameliore-mais-des-progres-restent-a-faire/feed 0 http://www.mypharma-editions.com/etude-desir-un-score-predictif-du-diabete-de-type-2-en-france http://www.mypharma-editions.com/etude-desir-un-score-predictif-du-diabete-de-type-2-en-france#comments Tue, 03 Mar 2009 11:05:47 +0000 morgdave http://www.mypharma-editions.com/?p=4509 http://www.mypharma-editions.com/etude-desir-un-score-predictif-du-diabete-de-type-2-en-france/feed 0 http://www.mypharma-editions.com/enquete-espad-2007-la-consommation-dalcool-en-hausse-chez-les-adolescents http://www.mypharma-editions.com/enquete-espad-2007-la-consommation-dalcool-en-hausse-chez-les-adolescents#comments Tue, 03 Feb 2009 10:30:29 +0000 morgdave http://www.mypharma-editions.com/?p=3696 http://www.mypharma-editions.com/enquete-espad-2007-la-consommation-dalcool-en-hausse-chez-les-adolescents/feed 0 http://www.mypharma-editions.com/la-premiere-carte-genetique-de-lobesite-severe-etablie-grace-aux-puces-a-adn http://www.mypharma-editions.com/la-premiere-carte-genetique-de-lobesite-severe-etablie-grace-aux-puces-a-adn#comments Mon, 19 Jan 2009 09:41:16 +0000 morgdave http://www.mypharma-editions.com/?p=3251 http://www.mypharma-editions.com/la-premiere-carte-genetique-de-lobesite-severe-etablie-grace-aux-puces-a-adn/feed 0 http://www.mypharma-editions.com/5eme-journee-nationale-de-prevention-et-dinformation-sur-lobesite-infantile http://www.mypharma-editions.com/5eme-journee-nationale-de-prevention-et-dinformation-sur-lobesite-infantile#comments Thu, 08 Jan 2009 09:49:47 +0000 morgdave http://www.mypharma-editions.com/?p=2657 http://www.mypharma-editions.com/5eme-journee-nationale-de-prevention-et-dinformation-sur-lobesite-infantile/feed 0 http://www.mypharma-editions.com/le-diabete-chez-les-enfants-et-les-adolescents http://www.mypharma-editions.com/le-diabete-chez-les-enfants-et-les-adolescents#comments Fri, 14 Nov 2008 08:45:01 +0000 morgdave http://www.mypharma-editions.com/?p=1564 http://www.mypharma-editions.com/le-diabete-chez-les-enfants-et-les-adolescents/feed 0 http://www.mypharma-editions.com/diabete-la-maladie-touche-25-millions-de-francais http://www.mypharma-editions.com/diabete-la-maladie-touche-25-millions-de-francais#comments Wed, 12 Nov 2008 10:12:17 +0000 morgdave http://www.mypharma-editions.com/?p=1501 http://www.mypharma-editions.com/diabete-la-maladie-touche-25-millions-de-francais/feed 0 http://www.mypharma-editions.com/la-journee-mondiale-du-diabete-se-deroulera-le-14-novembre-prochain http://www.mypharma-editions.com/la-journee-mondiale-du-diabete-se-deroulera-le-14-novembre-prochain#comments Tue, 11 Nov 2008 15:14:39 +0000 morgdave http://www.mypharma-editions.com/?p=1485 http://www.mypharma-editions.com/la-journee-mondiale-du-diabete-se-deroulera-le-14-novembre-prochain/feed 0 http://www.mypharma-editions.com/recherche-l%e2%80%99apeline-au-secours-des-diabetiques http://www.mypharma-editions.com/recherche-l%e2%80%99apeline-au-secours-des-diabetiques#comments Fri, 07 Nov 2008 09:06:03 +0000 morgdave http://www.mypharma-editions.com/?p=1416 http://www.mypharma-editions.com/recherche-l%e2%80%99apeline-au-secours-des-diabetiques/feed 0 http://www.mypharma-editions.com/federation-internationale-du-diabete-ann-keeling-rejoint-lorganisation-au-poste-de-directeur-general http://www.mypharma-editions.com/federation-internationale-du-diabete-ann-keeling-rejoint-lorganisation-au-poste-de-directeur-general#comments Wed, 05 Nov 2008 14:34:08 +0000 morgdave http://www.mypharma-editions.com/?p=1382 http://www.mypharma-editions.com/federation-internationale-du-diabete-ann-keeling-rejoint-lorganisation-au-poste-de-directeur-general/feed 0